Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001014108-24-000048
Filing Date
2024-10-02
Accepted
2024-10-02 15:56:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13GA - AMENDMENT NO. 1 ci-sc13ga_amend1.htm SC 13G/A 69730
  Complete submission text file 0001014108-24-000048.txt   71112
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Subject) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91949 | Film No.: 241347069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 158 FILMORE STREET DENVER CO 80206
Business Address
Ugwumba Chidozie (Filed by) CIK: 0001835544 (see all company filings)

Type: SC 13G/A